CAW
VRTX icon

Cornerstone Advisors (Washington)’s Vertex Pharmaceuticals VRTX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-957
Closed -$175K – 1359
2019
Q2 		$175K Buy
957
+14
+1% +$2.45K 0.02% 171
2019
Q1 		$173K Buy
943
+84
+10% +$15.5K 0.02% 159
2018
Q4 		$142K Sell
859
-1
-0.1% -$173 0.03% 156
2018
Q3 		$166K Sell
860
-144
-14% -$25.6K 0.11% 148
2018
Q2 		$171K Buy
1,004
+20
+2% +$3.1K 0.12% 140
2018
Q1 		$160K Hold
984
– – 0.11% 139
2017
Q4 		$147K Hold
984
– – 0.1% 149
2017
Q3 		$150K Buy
984
+159
+19% +$23.9K 0.1% 149
2017
Q2 		$106K Sell
825
-159
-16% -$19.1K 0.06% 180
2017
Q1 		$108K Hold
984
– – 0.06% 180
2016
Q4 		$72K Buy
984
+243
+33% +$19.8K 0.06% 207
2016
Q3 		$65K Buy
741
+281
+61% +$26.6K 0.05% 219
2016
Q2 		$40K Buy
460
+12
+3% +$1.04K 0.04% 181
2016
Q1 		$36K Buy
448
+51
+13% +$4.61K 0.04% 198
2015
Q4 		$50K Sell
397
-82
-17% -$9.9K 0.05% 179
2015
Q3 		$50K Hold
479
– – 0.04% 175
2015
Q2 		$59K Hold
479
– – 0.05% 158
2015
Q1 		$57K Buy
479
+241
+101% +$28.9K 0.04% 176
2014
Q4 		$28K Buy
238
+9
+4% +$1.01K 0.02% 239
2014
Q3 		$26K Sell
229
-4
-2% -$381 0.02% 116
2014
Q2 		$22K Hold
233
– – 0.02% 139
2014
Q1 		$16K Buy
233
+211
+959% +$16.7K 0.02% 155
2013
Q4 		$2K Hold
22
– – ﹤0.01% 265
2013
Q3 		$2K Hold
22
– – ﹤0.01% 243
2013
Q2 		$2K Buy
+22
New +$1.62K ﹤0.01% 202

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cornerstone Advisors (Washington)'s VRTX Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2019, closing a stake of 957 shares — an estimated $175K sold.

Cornerstone Advisors (Washington) first reported a position in VRTX in Q2 2013 and held it in 25 quarters. The position peaked at $175K in Q2 2019. 708 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Vertex Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 957 Vertex Pharmaceuticals shares in Q3 2019, an estimated $175K.
  • Cornerstone Advisors (Washington) first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s Vertex Pharmaceuticals position peaked at $175K in Q2 2019.
  • 708 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.